Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10166183 Pharmaceutical formulations

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 5, 2015
0
Date of Patent
January 1, 2019
0
Patent Application Number
15116970
0
Patent Citations Received
‌
US Patent 11744836 Dry powder treprostinil for the treatment of pulmonary hypertension
‌
US Patent 11357772 Methods for the treatment of abnormal involuntary movement disorders
‌
US Patent 11389450 Amorphous nilotinib microparticles and uses thereof
‌
US Patent 11446291 Methods for the treatment of abnormal involuntary movement disorders
‌
US Patent 11969413 Pharmaceutical compositions of deutetrabenazine and process for preparation thereof
0
‌
US Patent 11998548 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 12016858 Methods for the treatment of abnormal involuntary movement disorders
0
‌
US Patent 12016861 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 11559485 Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
‌
US Patent 11564917 Methods for the treatment of abnormal involuntary movement disorders
•••
Patent Inventor Names
Chengzhi Zhang
0
John Carter
0
Margaret Bradbury
0
Andreas Sommer
0
John Arthur
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10166183
0
Patent Primary Examiner
‌
Brian J Davis
0

Find more entities like US Patent 10166183 Pharmaceutical formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo